Skip to main content
Terug
Watch Compare

Larimar Therapeutics, Inc.

Datakwaliteit: 83%
LRMR
Nasdaq Manufacturing Chemicals
€ 4,85
▼ € 0,24 (-4,72%)
Marktkapitalisatie: 503,83 M
Prijs
€ 4,85
Marktkapitalisatie
503,83 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -113,29 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-127,99%
Onder sectorgemiddelde (-53,34%)
ROIC-102,63%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio4,06
Interest CoverageN/A

Waardering

PE (TTM|NTM)
-3,04 | -2,69
Onder sectorgemiddelde (-1,47)
P/B Ratio3,62
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -3,0 -1,5
P/B 3,6 1,6
ROE % -128,0 -53,3
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Koersdoel Analisten

10 analisten
Buy
Huidig
€ 4,85
+244.3%
Koersdoel
€ 16,70
€ 7,00
€ 16,00
€ 26,00
Vooruitzicht
Forward K/W -2,69
Forward WPA -€ 1,80
Omzet Sch. 62,61 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 1,80
-€ 2,95 – -€ 0,67
 62,61 M 4
FY2026 -€ 2,19
-€ 2,95 – -€ 1,64
 0,0 6

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,55 -€ 0,73 -33,8%
Q32025 -€ 0,42 -€ 0,61 -44,2%
Q22025 -€ 0,49 -€ 0,41 +15,6%
Q12025 -€ 0,41 -€ 0,46 -12,4%

ETFs Holding This Stock

BRSIX BRSIX
0,21% weight
GTTUX GTTUX
0,09% weight
GTTRX GTTRX
0,09% weight
GSATX GSATX
0,09% weight
GSCTX GSCTX
0,09% weight
GSITX GSITX
0,09% weight
GSXPX GSXPX
0,09% weight
GTTTX GTTTX
0,09% weight
GSIOX GSIOX
0,03% weight
GSCOX GSCOX
0,03% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -165,67 M
ROE -127,99% ROA -98,22%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -113,29 M
ROIC -102,63% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4,06
Interest Coverage N/A Asset Turnover N/A
Working Capital 138,11 M Tangible Book Value 139,04 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3,04 Forward P/E -2,69
P/B Ratio 3,62 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 8,05 Fwd Earnings Yield N/A
FCF Yield -22,49%
Market Cap 503,83 M Enterprise Value 413,69 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share -1,09 OCF / Share -1,09
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 68,38%
SBC-Adj. FCF -120,70 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -165,67 M -80,60 M -36,95 M -35,36 M -50,64 M
EPS (Diluted) — -1,32 -0,84 -1,37 -2,95
Gross Profit — — — — —
Operating Income -172,50 M -90,89 M -41,76 M -36,53 M -50,47 M
EBITDA — — — — —
R&D Expenses 154,22 M 73,28 M 27,67 M 24,25 M 38,40 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 145,84 M 200,23 M 95,94 M 126,41 M 78,67 M
Total Liabilities 67,76 M 28,41 M 14,22 M 15,50 M 14,25 M
Shareholders' Equity 78,09 M 171,81 M 81,72 M 110,90 M 64,41 M
Total Debt — — — — —
Cash & Equivalents 85,41 M 33,22 M 26,75 M 26,83 M 70,10 M
Current Assets 142,02 M 195,30 M 90,18 M 120,74 M 72,20 M
Current Liabilities 64,80 M 24,36 M 9,51 M 10,71 M 8,85 M